Oncofactor (Seattle, WA) a development stage biopharmaceutical company focused on oncology, closed a $2.1M Series A financing. Participants include Accelerator, OVP Venture Partners, Alexandria Real Estate Equities, Amgen Ventures, ARCH Venture Partners and WRF Capital.